These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9416336)

  • 1. Transport of human beta-amyloid peptide through the rat blood-brain barrier after global cerebral ischemia.
    Pluta R; Misicka A; Januszewski S; Barcikowska M; Lipkowski AW
    Acta Neurochir Suppl; 1997; 70():247-9. PubMed ID: 9416336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of blood-brain barrier permeability/leakage for circulating human Alzheimer's beta-amyloid-(1-42)-peptide.
    Pluta R; Barcikowska M; Januszewski S; Misicka A; Lipkowski AW
    Neuroreport; 1996 May; 7(7):1261-5. PubMed ID: 8817545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic rats as a model in the study of the neurobiological role of human beta-amyloid peptide. Time-dependent disappearing diffuse amyloid plaques in brain.
    Pluta R; Barcikowska M; Misicka A; Lipkowski AW; Spisacka S; Januszewski S
    Neuroreport; 1999 Nov; 10(17):3615-9. PubMed ID: 10619654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible reverse transport of beta-amyloid peptide across the blood-brain barrier.
    Pluta R; Misicka A; Barcikowska M; Spisacka S; Lipkowski AW; Januszewski S
    Acta Neurochir Suppl; 2000; 76():73-7. PubMed ID: 11450095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evidence that beta-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability.
    Strazielle N; Ghersi-Egea JF; Ghiso J; Dehouck MP; Frangione B; Patlak C; Fenstermacher J; Gorevic P
    J Neuropathol Exp Neurol; 2000 Jan; 59(1):29-38. PubMed ID: 10744033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy.
    Mackic JB; Weiss MH; Miao W; Kirkman E; Ghiso J; Calero M; Bading J; Frangione B; Zlokovic BV
    J Neurochem; 1998 Jan; 70(1):210-5. PubMed ID: 9422364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta.
    Martel CL; Mackic JB; Matsubara E; Governale S; Miguel C; Miao W; McComb JG; Frangione B; Ghiso J; Zlokovic BV
    J Neurochem; 1997 Nov; 69(5):1995-2004. PubMed ID: 9349544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation Combined with Ischemia Produces Myelin Injury and Plaque-Like Aggregates of Myelin, Amyloid-β and AβPP in Adult Rat Brain.
    Zhan X; Cox C; Ander BP; Liu D; Stamova B; Jin LW; Jickling GC; Sharp FR
    J Alzheimers Dis; 2015; 46(2):507-23. PubMed ID: 25790832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astroglial expression of the beta-amyloid in ischemia-reperfusion brain injury.
    Pluta R
    Ann N Y Acad Sci; 2002 Nov; 977():102-8. PubMed ID: 12480738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic blood-brain barrier and amyloid in white matter as etiological factors in leukoaraiosis.
    Pluta R; Januszewski S; Ułamek M
    Acta Neurochir Suppl; 2008; 102():353-6. PubMed ID: 19388344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier.
    Poduslo JF; Curran GL
    Neuroreport; 2001 Oct; 12(15):3197-200. PubMed ID: 11711855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of Amyloid-β Protein Precursor, β-Secretase, Presenilin 1 and 2 Genes in the Rat Selectively Vulnerable CA1 Subfield of Hippocampus Following Transient Global Brain Ischemia.
    Kocki J; Ułamek-Kozioł M; Bogucka-Kocka A; Januszewski S; Jabłoński M; Gil-Kulik P; Brzozowska J; Petniak A; Furmaga-Jabłońska W; Bogucki J; Czuczwar SJ; Pluta R
    J Alzheimers Dis; 2015; 47(4):1047-56. PubMed ID: 26401782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats.
    Jancsó G; Domoki F; Sántha P; Varga J; Fischer J; Orosz K; Penke B; Becskei A; Dux M; Tóth L
    Neurosci Lett; 1998 Sep; 253(2):139-41. PubMed ID: 9774169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active clearance of human amyloid beta 1-42 peptide aggregates from the rat ventricular system.
    Nakagawa Y; Yuzuriha T; Iwaki T
    Neuropathology; 2004 Sep; 24(3):194-200. PubMed ID: 15484697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of apolipoprotein E in the deposition of beta-amyloid peptide during ischemia-reperfusion brain injury. A model of early Alzheimer's disease.
    Pluta R
    Ann N Y Acad Sci; 2000 Apr; 903():324-34. PubMed ID: 10818522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
    Kaneko I; Morimoto K; Kubo T
    Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor.
    Wu D; Yang J; Pardridge WM
    J Clin Invest; 1997 Oct; 100(7):1804-12. PubMed ID: 9312181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to beta-amyloid decrease the blood-to-brain transfer of beta-amyloid peptide.
    Pan W; Solomon B; Maness LM; Kastin AJ
    Exp Biol Med (Maywood); 2002 Sep; 227(8):609-15. PubMed ID: 12192102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.